MOLECULAR PHARMACOLOGY
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
MOLECULAR PHARMACOLOGY
MOL PHARMACOL
ISSN / eISSN
0026-895X / 1521-0111
Aims and Scope
Molecular Pharmacology publishes findings derived from the application of innovative structural biology, biochemistry, biophysics, physiology, genetics, and molecular biology to basic pharmacological problems that provide mechanistic insights that are broadly important for the fields of pharmacology and toxicology. Relevant topics include:
Molecular Signaling / Mechanism of Drug Action
Chemical Biology / Drug Discovery
Structure of Drug-Receptor Complex
Systems Analysis of Drug Action
Drug Transport / Metabolism
Molecular Signaling / Mechanism of Drug Action
Chemical Biology / Drug Discovery
Structure of Drug-Receptor Complex
Systems Analysis of Drug Action
Drug Transport / Metabolism
Subject Area
PHARMACOLOGY & PHARMACY
CiteScore
7.50
View Trend
CiteScore Ranking
Category | Quartile | Rank |
---|---|---|
Pharmacology, Toxicology and Pharmaceutics - Pharmacology | Q1 | #72/301 |
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine | Q2 | #56/171 |
Web of Science Core Collection
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
Category (Journal Citation Reports 2023) | Quartile |
---|---|
PHARMACOLOGY & PHARMACY - SCIE | Q2 |
H-index
186
Country/Area of Publication
UNITED STATES
Publisher
American Society for Pharmacology and Experimental Therapeutics
Publication Frequency
Monthly
Year Publication Started
1965
Annual Article Volume
49
Open Access
NO
Contact
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS, 9650 ROCKVILLE PIKE, BETHESDA, USA, MD, 20814-3995
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started